<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-section" /><meta name="keywords" content="Antifungal drugs: skin; Fungal infections: skin; Tinea infections; Athlete’s foot; Infections: nail, fungal; Clotrimazole: skin; Econazole: skin; Ketoconazole: skin; Miconazole: skin; Terbinafine: topical; Griseofulvin: topical; Benzoic acid ointment, compound; Tolnaftate; Amorolfine; Tioconazole; Pityriasis versicolor; Ketoconazole: skin; Selenium sulphide; Clotrimazole: skin; Econazole: skin; Ketoconazole: skin; Miconazole: skin; Terbinafine: topical; Candidiasis: skin; Nystatin: skin; Angular cheilitis: fungal infection; Cheilitis, angular: fungal infection; Dental prescribing: infections: fungal" /><meta name="IX" content="Antifungal drugs: skin; Fungal infections: skin; Tinea infections; Athlete’s foot; Infections: nail, fungal; Clotrimazole: skin; Econazole: skin; Ketoconazole: skin; Miconazole: skin; Terbinafine: topical; Griseofulvin: topical; Benzoic acid ointment, compound; Tolnaftate; Amorolfine; Tioconazole; Pityriasis versicolor; Ketoconazole: skin; Selenium sulphide; Clotrimazole: skin; Econazole: skin; Ketoconazole: skin; Miconazole: skin; Terbinafine: topical; Candidiasis: skin; Nystatin: skin; Angular cheilitis: fungal infection; Cheilitis, angular: fungal infection; Dental prescribing: infections: fungal" /><title>13.10.2 Antifungal preparations: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="6148.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="6148.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=6148.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2080.htm">13 Skin</a> &gt; <a href="6114.htm">13.10 Anti-infective skin preparations</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="6143.htm" title="Previous: METRONIDAZOLE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="6149.htm" title="Next: AMOROLFINE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_6148">13.10.2 Antifungal preparations</h1><?highlighter on?><div id="pC" class="jN"><div><p>Most localised fungal infections are treated with topical preparations.
To prevent relapse, local antifungal treatment should be continued
for 1–2 weeks after the disappearance of all signs of infection. Systemic
therapy (<a title="BNF:target-block: Fungal skin and nail infections" href="102291.htm#_200994">section 5.2</a>) is necessary
for nail or scalp infection or if the skin infection is widespread,
disseminated, or intractable. Skin scrapings should be examined if
systemic therapy is being considered or where there is doubt about
the diagnosis.</p><div id="_6148.4"><div class="cAZ" id="_201036"><h2>Dermatophytoses</h2> <p class="cAX">Ringworm infection can affect the scalp (tinea capitis), body (tinea
corporis), groin (tinea cruris), hand (tinea manuum), foot (tinea
pedis, athlete’s
foot), or nail (tinea unguium). Scalp infection requires systemic treatment
(<a title="BNF:target-block: Fungal skin and nail infections" href="102291.htm#_200994">section 5.2</a>); additional
application of a topical antifungal, during  the early stages of treatment,
may reduce the risk of transmission. A topical antifungal can also
be used to treat asymptomatic carriers of scalp ringworm. Most other
local ringworm infections can be treated adequately with topical antifungal
preparations (including <a title="preparation-group: Shampoos" href="106490.htm#_106490">shampoos, section 13.9</a>). The imidazole antifungals <b><span>clotrimazole</span>, econazole, <span>ketoconazole</span></b>, and <b><span>miconazole</span></b> are all effective. <b><span>Terbinafine</span></b> cream is also effective but it is more expensive. Other
topical antifungals include <b>griseofulvin</b> and the <b><span>undecenoates</span></b>. <b>Compound <span>benzoic acid</span> ointment</b> (Whitfield’s ointment) has been used for ringworm infections but
it is cosmetically less acceptable than proprietary preparations.
Topical preparations for athlete’s foot containing <b>tolnaftate</b> are on sale to
the public.</p><p>Antifungal dusting powders are of little therapeutic value in
the treatment of fungal skin infections and may cause skin irritation;
they may have some role in preventing re-infection.</p> <p class="cAX">Antifungal treatment
may not be necessary in asymptomatic patients with tinea infection
of the nails. If treatment is necessary, a systemic antifungal (<a title="target-block: Fungal skin and nail infections" href="102291.htm#_200994">section 5.2</a>) is more
effective than topical therapy. However, topical application of <b><span>amorolfine</span></b> or <b><span>tioconazole</span></b> may be useful for treating
early onychomycosis when involvement is limited to mild distal disease
in up to 2 nails, or for superficial white onychomycosis, or where
there are contra-indications to systemic therapy.</p></div></div><div id="_6148.3"><div class="cAZ"><h2>Pityriasis versicolor</h2> <p class="cAX">Pityriasis (tinea) versicolor can be treated
with <b><span>ketoconazole</span></b> shampoo (<a title="preparation: Nizoral (reg.)" href="6103.htm#_6103">section 13.9</a>). Alternatively, <b><span>selenium
sulphide</span></b> shampoo [unlicensed indication] (<a title="preparation: Selsun (reg.)" href="6109.htm#_6109">section 13.9</a>) can be used as a lotion (diluting
with a small amount of water can reduce irritation) and left on the
affected area for 10 minutes before rinsing off; it should be applied
once daily for 7 days, and the course repeated if necessary.</p><p>Topical imidazole antifungals such as <b><span>clotrimazole</span></b>, <b><span>econazole</span></b>, <b><span>ketoconazole</span></b>,
and <b><span>miconazole</span></b>, or topical <b><span>terbinafine</span></b> are alternatives, but large quantities may be required.</p><p>If topical therapy fails, or if the infection is widespread,
pityriasis versicolor is treated systemically with a triazole antifungal
(<a title=" Antifungal drugs" href="3968.htm#_3968">section 5.2</a>). Relapse is common, especially in the immunocompromised.</p></div></div><div id="_6148.5"><div class="cAZ"><h2>Candidiasis</h2> <p class="cAX">Candidal skin infections can be treated with a topical
imidazole antifungal, such as <b><span>clotrimazole</span></b>, <b><span>econazole</span></b>, <b><span>ketoconazole</span></b>, or <b><span>miconazole</span></b>; topical <span>terbinafine</span> is an alternative.
Topical application of <b><span>nystatin</span></b> is also effective for
candidiasis but it is ineffective against dermatophytosis. Refractory
candidiasis requires systemic treatment (<a title="BNF:monograph-family: Treatment of fungal infections" href="102291.htm#_102291">section 5.2</a>) generally
with a triazole such as <span>fluconazole</span>; systemic treatment
with <span>terbinafine</span> is <b>not appropriate</b> for refractory candidiasis.</p></div></div><div id="_6148.1"><div class="cAZ"><h2>Angular cheilitis</h2> <p class="cAX">Miconazole cream is used in
the fissures of angular cheilitis when associated with <i>Candida</i>.
For further information on angular cheilitis, see <a title="target-block: Angular cheilitis" href="5702.htm#_5702.1">section 12.3.2</a>.</p></div></div><div class="cAZ"><h2>Compound topical preparations</h2> <p class="cAX">Combination of an
imidazole and a mild corticosteroid (such as <span>hydrocortisone</span> 1%) (<a title=" Topical corticosteroids" href="5837.htm#_5837">section 13.4</a>) may be of value in the treatment of eczematous
intertrigo and, in the first few days only, of a severely inflamed
patch of ringworm. Combination of a mild corticosteroid with either
an imidazole or <span>nystatin</span> may be of use in the treatment
of intertrigo associated with candida.</p></div><div class="cAZ" id="_6148.2"><h2>Cautions</h2> <p class="cAX">Contact with eyes and mucous membranes should be avoided.</p></div><div class="cAZ"><h2>Side-effects</h2> <p class="cAX">Occasional local irritation and hypersensitivity
reactions include mild burning sensation, erythema, and itching. Treatment
should be discontinued if these are severe.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_6149"><a href="6149.htm" title="AMOROLFINE">AMOROLFINE</a></li><li id="_6151"><a href="6151.htm" title="BENZOIC ACID">BENZOIC ACID</a></li><li id="_6155"><a href="6155.htm" title="CLOTRIMAZOLE">CLOTRIMAZOLE</a></li><li id="_6158"><a href="6158.htm" title="ECONAZOLE NITRATE">ECONAZOLE NITRATE</a></li><li id="_129234"><a href="129234.htm" title="GRISEOFULVIN">GRISEOFULVIN</a></li><li id="_6161"><a href="6161.htm" title="KETOCONAZOLE">KETOCONAZOLE</a></li><li id="_6163"><a href="6163.htm" title="MICONAZOLE NITRATE">MICONAZOLE NITRATE</a></li><li id="_6165"><a href="6165.htm" title="NYSTATIN">NYSTATIN</a></li><li id="_6169"><a href="6169.htm" title="SALICYLIC ACID">SALICYLIC ACID</a></li><li id="_6174"><a href="6174.htm" title="TERBINAFINE">TERBINAFINE</a></li><li id="_6176"><a href="6176.htm" title="TIOCONAZOLE">TIOCONAZOLE</a></li><li id="_6178"><a href="6178.htm" title="UNDECENOATES">UNDECENOATES</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="6143.htm">Previous: METRONIDAZOLE</a> | <a class="top" href="6148.htm#">Top</a> | <a accesskey="]" href="6149.htm">Next: AMOROLFINE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>